NCT05588466

Brief Summary

Hypertension (HTN) is the most prevalent modifiable risk factor for cardiovascular disease among U.S. adults. Despite a long history of established guidelines to support clinical management, only half of U.S. adults diagnosed with HTN have poorly controlled blood pressure (BP) and medication adherence to proven effective treatment remains suboptimal. Clinical decision support (CDS) has the potential to overcome barriers to delivering guideline-recommended care and improve HTN management. Practice facilitation is a well-demonstrated implementation strategy to support process changes and has the potential to facilitate CDS implementation. Our objective is to rigorously evaluate whether practice facilitation provided in concert with a HTN-focused CDS that incorporates medication adherence results is an effective strategy for scaling and implementing CDS. The investigators will update an existing CDS to incorporate alerts and tools to address medication adherence then randomize 40 small independent primary care practices in New York City to receive either practice facilitation in addition to the CDS or the CDS alone. After a twelve-month intervention period, The investigators will examine the differences in blood pressure control achieved by practices in the CDS plus practice facilitation group versus practices that received the CDS alone

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 9, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 7, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 20, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

May 22, 2025

Status Verified

May 1, 2025

Enrollment Period

3.2 years

First QC Date

April 7, 2022

Last Update Submit

May 19, 2025

Conditions

Keywords

Clinical Decision Support SystemPractice FacilitationSmall Independent Practices

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled using BP documented in the electronic health record

    The primary outcome will be a measure of clinical effectiveness, or the percentage of patients who have achieved BP control, defined as BP \<140/90 mmHg in the mean of the last two EHR-recorded measurements during each of the pre-intervention and post-intervention study periods.

    12-months

Secondary Outcomes (2)

  • Change in average systolic and diastolic blood pressure (mmHg) of patients who had a diagnosis of hypertension (HTN) using BP documented in the electronic health record

    12-months

  • Percentage of patients who had a diagnosis of hypertension (HTN) and a documented blood pressure (BP)-lowering medication and whose calculated medication adherence rate is considered adherent using pharmacy claims data

    12-months

Study Arms (2)

CDS alone

ACTIVE COMPARATOR

This arm will only receive the CDS.

Other: CDS Alone

CDS plus practice facilitation

ACTIVE COMPARATOR

This arm will receive the CDS and practice facilitation.

Other: CDS plus practice facilitation

Interventions

The practices in the 'CDS alone' arm will receive an updated CDS for HTN management.

CDS alone

The practices in the 'CDS plus practice facilitation' arm will receive an updated CDS for HTN management plus practice facilitation to support the adoption of the CDS.

CDS plus practice facilitation

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • an outpatient clinic visit with an HTN diagnosis based on the ICD-10 code in the prior 12 months
  • must have received care at the clinic for at least 12 months

You may not qualify if:

  • not pregnant
  • not have end-stage kidney disease as defined by an ICD-10 code for dialysis or transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYC Department of Health and Mental Hygiene

Queens, New York, 11101, United States

Location

Related Publications (1)

  • Blecker S, Gannon M, De Leon S, Shelley D, Wu WY, Tabaei B, Magno J, Pham-Singer H. Practice facilitation for scale up of clinical decision support for hypertension management: study protocol for a cluster randomized control trial. Contemp Clin Trials. 2023 Jun;129:107177. doi: 10.1016/j.cct.2023.107177. Epub 2023 Apr 8.

MeSH Terms

Conditions

Hypertension

Interventions

Compact Disks

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Videodisc RecordingOptical Storage DevicesAudiovisual AidsEducational TechnologyTechnologyTechnology, Industry, and AgricultureTelevision

Study Officials

  • Duncan Maru

    NYC DOHMH

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2022

First Posted

October 20, 2022

Study Start

June 9, 2021

Primary Completion

August 30, 2024

Study Completion

September 30, 2024

Last Updated

May 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

There is a plan to share individual participant data with our collaborating investigators at NYU School of Medicine on this study. There is a data sharing agreement between NYC DOHMH and NYU School of Medicine that specifies that the co-Principal Investigators on this study and the other investigators listed in the IRB application. Information will be shared with our collaborators at NYU School of Medicine using the secure mechanism/ software, BisCom. Data will be stored in secured folders with access restricted to investigators listed on this IRB, at NYU School of Medicine, in accordance with privacy and security protocols of NYU School of Medicine and NYC Department of Health and Mental Hygiene.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will be available from 4/1/2022 through 10/1/2026.
Access Criteria
The investigators will have access to all data sets obtained and data collected for the purposes of this study, including de-identified patient-level EHR data (i.e., demographics, encounter date, encounter information such as medication and lab orders, blood pressure and clinical decision support usage metrics \[acknowledgement of alerts, and use of order sets\]); Salesforce data on practice demographics, practice facilitation and clinical decision support implementation as needed to deploy surveys, conduct interviews and collaborate with DOHMH investigators on analyses.

Locations